Profile of endothelial and leukocyte activation in Fabry patients

Annals of Neurology

Volumn 47, Issue 2, 2000, Pages 229-233

  DeGraba, Thomas ^a,e   Azhar, Salman ^a   Dignat George, Françoise ^b   Brown, Eric ^a   Boutière, Brigitte ^a   Altarescu, Gheona ^c   McCarron, Richard ^d   Schiffmann, Raphael ^c  

^a Federal Building   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NAVAL MEDICAL RESEARCH CENTER   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOMODULIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FABRY DISEASE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; STROKE; X CHROMOSOME RECESSIVE DISORDER;

ADULT; ENDOTHELIUM, VASCULAR; FABRY DISEASE; HUMANS; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MIDDLE AGED; P-SELECTIN; REFERENCE VALUES; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033950217     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T     Document Type: Article

References (30)

1. Desnick RJ, Ioannou YA, Eng CH. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995:2741-2784
2. Kaye EM, Kolodny EH, Logogian EL, et al. Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 1988;23:505-509
3. DeVeber GA, Schwarting GA, Kolodny, et al. Fabry disease: immunocytochemical characterization of neural involvement. Ann Neurol 1992;31:409-415
4. Grewal RP, Stroke in Fabry's disease. J Neurol 1994;241:153-156
5. Crutchfield KE, Patronas NJ, Dambrosia JM, et al. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 1998;50:1746-1749
6. Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Ann Neurol 1996;40:8-17
7. Utsumi K, Yamamoto N, Kase R, et al. High incidence of thrombosis in Fabry's disease. Intern Med 1997;36:327-329
8. Scalia R, Appel JZ, Lefer AM. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol 1998;18:1093-1100
9. Arai T, Bhunia AK, Chatterjee S, et al. Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ Res 1998;82:540-547
10. Abbas AK, Lichtman AH, Pober JS. Cytokines. In: Abbas AK, Lichtman AH, Pober JS, eds. Cellular and molecular immunology. 2nd ed. Philadelphia: WB Saunders, 1994:240-260
11. Bevilaqua MP, Pober JS, Majeau GR. Interleukin-1 induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-623
12. Nawroth PP, Handley DA, Esmon CT, et al. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83:3460-3464
13. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163: 740-745
14. Bevilaqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Acad Sci USA 1986;83: 4533-4537
15. Sterns DM, Kaiser E, Nawroth PP. Regulation of the coagulation system by vascular endothelial cells. Haemostasis 1988;18: 202-214
16. Blann A. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993;50:125-134
17. Dawson G, Kruski AW, Scanu AM. Distribution of glycosphingolipids in serum lipoproteins of normal human subjects and patients with hypo and hyperlipidemia. J Lipid Res 1976; 17:125-131
18. Clarke JTR, Stotlz JM, Mulcahy MR. Neutral glycosphingolipids of serum lipoproteins in Fabry's disease. Biochim Biophys Acta 1976;431:317-325
19. Chatterjee S, Kwiterovich PO. Glycosphingolipids and plasma lipoproteins: a review. Can J Biochem Cell Biol 1984;62:385-397
20. Brady RO. Genetic errors and enzyme replacement strategies. Res Publ Assoc Res Nerv Ment Dis 1983;60:181-193
21. Gornati R, Bembi B, Tong X, et al. Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy. Clin Chim Acta 1998;271:151-161
22. Pearson JD. Endothelial cell function and thrombosis. Baillieres Clin Haematol 1994;7:441-452
23. Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 1998;18:1523-1533
24. Hakomori S. Bifunctional role of glycosphingolipids. J Biol Chem 1990;265:18713-18716
25. Marx N, Neumann F-J, Zohlnhöfer D, et al. Enhancement of monocyte procoagulant activity by adhesion on vascular smooth muscle cells and intercellular adhesion molecule-1-transfected Chinese hamster ovary cells. Circulation 1998;98:906-911
26. DeGraba TJ, Siren AL, Penix L, et al. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke 1998;29:1405-1410
27. Miwa K, Igawa A, Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 1997;36:37-44
28. Dignat-George F, Teysseire N, Mutin M, et al. Rickettsia conorii infection enhances vascular cell adhesion-1 and intercellular adhesion molecule-1 dependent mononuclear cell adherence to endothelial cells. J Infect Dis 1997;175:1142-1152
29. George F, Brouqui P, Boffa MC, et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993;82:2109-2116
30. Brady RO, Tallman JF, Johnson WG, et al. Replacement therapy for inherited enzyme deficiency: use of purified ceramidetrihexosidase in Fabry's disease. N Engl J Med 1973;289:9-14